市場調査レポート

商品コード

1316903

気管支炎治療市場：タイプ別（急性気管支炎、慢性気管支炎）、治療薬別（薬剤、酸素療法）、薬剤クラス別、エンドユーザー別-2023-2030年の世界予測

Bronchitis Treatment Market by Type (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Class of Drugs, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

気管支炎治療の世界市場は大きく成長し、2023年には67億2,122万米ドルが予測され、CAGRは6.73%、2030年には106億2,040万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の気管支炎治療市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.気管支炎治療の世界市場規模および予測は？

2.予測期間中、世界の気管支炎治療市場を形成するCOVID-19の阻害要因と影響は？

3.気管支炎治療の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.気管支炎治療の世界市場における競争戦略は？

5.気管支炎治療の世界市場における技術動向と規制の枠組みは？

6.気管支炎治療の世界市場における主要ベンダーの市場シェアは？

7.気管支炎治療の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 気管支炎の発生率の急増に伴う高齢者人口の増加
  - COPD患者の有病率の上昇
  - 気管支炎に対する意識の高まり
- 抑制要因
  - 医薬品の特許が切れる
- 機会
  - 併用療法や小細胞療法などのCOPD治療の進歩
  - 新興経済諸国における治療の啓発と市場への浸透のための政府との協力的な取り組み
- 課題
  - 酸素療法に関連するリスクと副作用
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章気管支炎治療市場：タイプ別

急性気管支炎
慢性気管支炎

第7章気管支炎治療市場治療別

薬物
酸素療法

第8章気管支炎治療市場薬物のクラス別

抗炎症薬
抗生物質
気管支拡張薬

第9章気管支炎治療市場：エンドユーザー別

クリニック
病院薬局
小売薬局

第10章南北アメリカの気管支炎治療市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第11章アジア太平洋地域の気管支炎治療市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第12章欧州・中東・アフリカの気管支炎治療市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第13章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第14章掲載企業一覧

第15章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. BRONCHITIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. BRONCHITIS TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. BRONCHITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 5. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 6. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2022 VS 2030 (%)
FIGURE 7. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 8. BRONCHITIS TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 9. BRONCHITIS TREATMENT MARKET DYNAMICS
FIGURE 10. BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. BRONCHITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 19. BRONCHITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. BRONCHITIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. BRONCHITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 5. BRONCHITIS TREATMENT MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. BRONCHITIS TREATMENT MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. BRONCHITIS TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BRONCHITIS TREATMENT MARKET SIZE, BY OXYGEN THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 11. BRONCHITIS TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BRONCHITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BRONCHITIS TREATMENT MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. BRONCHITIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BRONCHITIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BRONCHITIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 34. CANADA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 38. MEXICO BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 56. CHINA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 60. INDIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 68. JAPAN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 92. THAILAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 105. DENMARK BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 108. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 109. EGYPT BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 113. FINLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 120. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 121. GERMANY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 129. ITALY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 141. NORWAY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 144. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 145. POLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 149. QATAR BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 164. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 165. SPAIN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 176. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 177. TURKEY BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY CLASS OF DRUGS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BRONCHITIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. BRONCHITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 187. BRONCHITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 188. BRONCHITIS TREATMENT MARKET LICENSE & PRICING

Product Code: MRR-A26E0E5742AA

The Global Bronchitis Treatment Market is forecasted to grow significantly, with a projected USD 6,721.22 million in 2023 at a CAGR of 6.73% and expected to reach a staggering USD 10,620.40 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Bronchitis Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Bronchitis Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Acute Bronchitis and Chronic Bronchitis. The Acute Bronchitis is projected to witness significant market share during forecast period.

Based on Treatment, market is studied across Drugs and Oxygen Therapy. The Drugs is projected to witness significant market share during forecast period.

Based on Class of Drugs, market is studied across Anti-inflammatory Drugs, Antibiotics, and Bronchodilator. The Antibiotics is projected to witness significant market share during forecast period.

Based on End User, market is studied across Clinics, Hospital Pharmacies, and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Bronchitis Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bronchitis Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bronchitis Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bronchitis Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Bronchitis Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Bronchitis Treatment Market?

6. What is the market share of the leading vendors in the Global Bronchitis Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Bronchitis Treatment Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Bronchitis Treatment Market, by Type, 2022 vs 2030
4.3. Bronchitis Treatment Market, by Treatment, 2022 vs 2030
4.4. Bronchitis Treatment Market, by Class of Drugs, 2022 vs 2030
4.5. Bronchitis Treatment Market, by End User, 2022 vs 2030
4.6. Bronchitis Treatment Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increase in geriatric population with surge in incidence of bronchitis
  - 5.1.1.2. Rising prevalence of COPD patients
  - 5.1.1.3. Rising awareness regarding bronchitis
- 5.1.2. Restraints
  - 5.1.2.1. Patent expiry of drugs
- 5.1.3. Opportunities
  - 5.1.3.1. Advances in the COPD therapies such as combination therapies and small cell therapy
  - 5.1.3.2. Collaborative initiatives with government for treatment awareness and market penetration in developing economies
- 5.1.4. Challenges
  - 5.1.4.1. Risk and side effects associated with oxygen therapy
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Bronchitis Treatment Market, by Type

6.1. Introduction
6.2. Acute Bronchitis
6.3. Chronic Bronchitis

7. Bronchitis Treatment Market, by Treatment

7.1. Introduction
7.2. Drugs
7.3. Oxygen Therapy

8. Bronchitis Treatment Market, by Class of Drugs

8.1. Introduction
8.2. Anti-inflammatory Drugs
8.3. Antibiotics
8.4. Bronchodilator

9. Bronchitis Treatment Market, by End User

9.1. Introduction
9.2. Clinics
9.3. Hospital Pharmacies
9.4. Retail Pharmacies

10. Americas Bronchitis Treatment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Bronchitis Treatment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Bronchitis Treatment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

気管支炎治療市場：タイプ別（急性気管支炎、慢性気管支炎）、治療薬別（薬剤、酸素療法）、薬剤クラス別、エンドユーザー別-2023-2030年の世界予測

Bronchitis Treatment Market by Type (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Class of Drugs, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 気管支炎治療市場：タイプ別

第7章 気管支炎治療市場治療別

第8章 気管支炎治療市場薬物のクラス別

第9章 気管支炎治療市場：エンドユーザー別

第10章 南北アメリカの気管支炎治療市場

第11章 アジア太平洋地域の気管支炎治療市場

第12章 欧州・中東・アフリカの気管支炎治療市場

第13章 競合情勢

第14章 掲載企業一覧

第15章 付録